A 12-week, randomized, double-blind, multi-center, vehicle-controlled, parallel group study to assess the efficacy and safety of the diclofenac sodium gel 1% (DSG 1%) for the relief of signs and symptoms in subjects with OA of the knee.
Phase of Trial: Phase III
Latest Information Update: 01 Jun 2012
At a glance
- Drugs Diclofenac (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions; Therapeutic Use
- 01 Jun 2012 New trial record